Temoporfin
Foscan (temoporfin) is a small molecule pharmaceutical. Temoporfin was first approved as Foscan on 2001-10-24. It has been approved in Europe to treat head and neck neoplasms and squamous cell carcinoma.
Trade Name | Foscan |
---|---|
Common Name | Temoporfin |
Indication | head and neck neoplasms, squamous cell carcinoma |
Drug Class | Benzoporphyrin derivatives |